Two Mu Opioids Set for FDA Advisory Review

(MedPage Today) -- Oliceridine abuse potential raises concern; outlook better for sufentanil sublingual tablets
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news
More News: Primary Care